Literature DB >> 10918267

Analysis of muscle proteins in acute quadriplegic myopathy.

N Matsumoto1, T Nakamura, Y Yasui, J Torii.   

Abstract

We investigated the changes of muscle proteins in acute quadriplegic myopathy (AQM) using immunohistochemistry and stoichiometry. Cases of AQM were observed in which it was difficult to type muscle fibers with adenosine triphosphatase staining in biopsied muscle. Well-defined typing of these cases was possible by performing immunofluorescent staining using slow and fast skeletal troponin I (TnI) antibodies. By this means, small angular fibers were shown to be fast skeletal muscle, and myosin was absent from these muscle fibers. Actin and tropomyosin were maintained. Muscle protein ratios were determined by stoichiometry following sodium dodecyl sulfate-polyacrylamide gel electrophoresis of AQM myofibril specimens from four subjects. The myosin heavy chain/actin ratio was significantly decreased compared with a normal control group and other neuromuscular diseases. These pathologic findings returned to normal during recovery from AQM. Thus, myosin selectively decreases, whereas actin and regulatory proteins located above it are maintained during AQM. Copyright 2000 John Wiley & Sons, Inc.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10918267     DOI: 10.1002/1097-4598(200008)23:8<1270::aid-mus18>3.0.co;2-e

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN: 0148-639X            Impact factor:   3.217


  9 in total

1.  Electrophoretic determination of the myosin/actin ratio in the diagnosis of critical illness myopathy.

Authors:  Helena Stibler; Lars Edström; Karsten Ahlbeck; Sten Remahl; Tor Ansved
Journal:  Intensive Care Med       Date:  2003-08-12       Impact factor: 17.440

2.  Myofibrillar protein and gene expression in acute quadriplegic myopathy.

Authors:  Holly Norman; Håkan Zackrisson; Yvette Hedström; Per Andersson; Jenny Nordquist; Lars I Eriksson; Rolf Libelius; Lars Larsson
Journal:  J Neurol Sci       Date:  2009-06-06       Impact factor: 3.181

3.  Muscle paralysis and myosin loss in a patient with cancer cachexia.

Authors:  V Banduseela; J Ochala; K Lamberg; H Kalimo; L Larsson
Journal:  Acta Myol       Date:  2007-12

Review 4.  Critical illness myopathy.

Authors:  David Lacomis
Journal:  Curr Rheumatol Rep       Date:  2002-10       Impact factor: 4.592

5.  Critical Illness Neuromyopathy Complicating Akinetic Crisis in Parkinsonism: Report of 3 Cases.

Authors:  Margherita Capasso; Maria Vittoria De Angelis; Antonio Di Muzio; Francesca Anzellotti; Laura Bonanni; Astrid Thomas; Marco Onofrj
Journal:  Medicine (Baltimore)       Date:  2015-07       Impact factor: 1.889

Review 6.  Approach to neuromuscular disorders in the intensive care unit.

Authors:  Kenneth C Gorson
Journal:  Neurocrit Care       Date:  2005       Impact factor: 3.210

7.  Mechanisms underlying ICU muscle wasting and effects of passive mechanical loading.

Authors:  Monica Llano-Diez; Guillaume Renaud; Magnus Andersson; Humberto Gonzales Marrero; Nicola Cacciani; Henrik Engquist; Rebeca Corpeño; Konstantin Artemenko; Jonas Bergquist; Lars Larsson
Journal:  Crit Care       Date:  2012-10-26       Impact factor: 9.097

8.  Masseter muscle myofibrillar protein synthesis and degradation in an experimental critical illness myopathy model.

Authors:  Hazem Akkad; Rebeca Corpeno; Lars Larsson
Journal:  PLoS One       Date:  2014-04-04       Impact factor: 3.240

9.  Impaired Ca(2+) release contributes to muscle weakness in a rat model of critical illness myopathy.

Authors:  Monica Llano-Diez; Arthur J Cheng; William Jonsson; Niklas Ivarsson; Håkan Westerblad; Vic Sun; Nicola Cacciani; Lars Larsson; Joseph Bruton
Journal:  Crit Care       Date:  2016-08-10       Impact factor: 9.097

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.